NCT03977116View on ClinicalTrials.gov

Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

January 1, 2019

Study Completion Date

March 1, 2019

Conditions
Diabetes MellitusHeart FailureVentricular Arrythmia
Interventions
DRUG

SLGT2

These patients will receive SLGT2 therapy after catheter ablation.

DRUG

Placebo

These patients will receive placebo therapy after catheter ablation.

Trial Locations (1)

80138

Raffaele Marfella, Naples

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT03977116 - Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients | Biotech Hunter | Biotech Hunter